AI-powered algorithms to drive the Newborn Metabolic Screening Market at a CAGR of 9.2%
Increasing birth rates across the world are expected to drive demand for newborn metabolic screening, as the risk of galactosemia, sickle cell disease, phenylketonuria, maple syrup urine disease, and cystic fibrosis is higher among infants. Various countries are implementing screening for metabolic diseases in newborns as a part of their immunization programs. To remain competitive and ensure a...
0 Commenti 0 condivisioni 2K Views 0 Anteprima